Epidemiological profile of prostate cancer mortality and access to hospital care in Brazilian regions - an ecological study

Authors

  • Stefanie de Sousa Antunes Alcantara University Center - FMABC, Santo André, São Paulo, Brazil
  • Patricia Merly Martinelli University Center - FMABC, Santo André, São Paulo, Brazil
  • Luiz Vinicius de Alcantara Sousa University Center - FMABC, Santo André, São Paulo, Brazil
  • Fernando Luiz Affonso Fonseca Clinical Laboratory University Center - FMABC, Santo André, São Paulo, Brazil

DOI:

https://doi.org/10.36311/jhgd.v31.12227

Keywords:

prostate cancer , Epidemiology, mortality , hospitalization

Abstract

Introduction: Due to the high incidence and mortality rates that cancer has, the World Health Organization (WHO) defines it as a public health problem and points out that there are approximately 10 million people affected by cancer, the estimate for the year 2020 will be 16 million of sick individuals.One of the most frequent neoplasms in the world, Prostate Cancer (CaP) (1.1 million), occupies 4th place, being behind only lung cancer (1.8 million), breast (1.7 million), and intestine (1.4 million). In the year 2012, approximately 1,112,000 new global cases of CaP were registered, with about 307,000 deaths.

 

Objective: To analyze the epidemiological profile of mortality from prostate cancer and the access of patients to health among Brazilian regions.

 

Methods: Ecological study based on secondary data from between the years 2000 and 2015. Mortality, hospitalization, and population were collected at the DATASUS. The variables were related to the epidemiological profile of CaP among Brazilian regions, stratified by the number of hospitalizations, of deaths, admission fee, mortality rate, and age group (40 to 79 years). The study looks at a time trend and gains access to health and mortality using regression models.

 

Results: The northern showed a greater decrease in cases from 40-59 years (β: -1,800; -0.46). Southeast, with a small reduction only between 40 and 44 years old (β: -0.345 and p: 0.665). Northeast, South, and Center-West regions did not express a drop in the hospitalization rate, with the greatest growth between 65 and 69 years old (β: 7,862; 11,346; and p> 0.05). The Midwest had the greatest increase between 55 and 59 years (β: 3,660, p: 0.098), followed by 65 to 69 years (β: 3,491, p: 0.314). Mortality rates indicated a reduction in the Southeast (β: - 0.440) and South (β: -0.361).

 

Conclusion: This study found an association with various environmental and economic cultures in each Brazilian region, being an important resource for the development of health services and their access to the population.

Downloads

Download data is not yet available.

References

Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.International Journal Of Cancer. 2010; 127(12): 2893-917.

Friestino JKO, Rezende R, Lorentz LH, Silva OMP. Mortalidade por câncer de próstata no Brasil: Contexto histórico e perspectivas. Revista Baiana de Saúde Pública. 2013; 37(3): 688-701. DOI: https://doi.org/10.22278/2318-2660.2013.v37.n3.a613

Czorny RCN, et al. Fatores de risco para o câncer de próstata: População de uma unidade básica de saúde. Cogitare Enfermagem.2017; 22(4): 1-10. DOI: http://dx.doi.org/10.5380/ce.v22i4.51823

Ministério da Saúde. Instituto Nacional De Câncer José Alencar Gomes Da Silva. [Coordenação Geral de Ações Estratégicas. Coordenação de Prevenção e Vigilância. Estimativa 2018: Incidência de câncer no Brasil. Rio de Janeiro] [acesso em 25 de abril de 2018]. Disponível em: http://www.inca.gov.br/estimativa/2018/

Ministério da Saúde. Instituto Nacional de Câncer. [Câncer de próstata] [acesso em 2018 maio de 2020]. Disponível em: http://www.inca.gov.br/impressão

Tao Z-Q, et al. Epidemiology of prostate cancer: current status. Eur Rev Med Pharmacol Sci. 2015; 19(5): 805-12.

Barbosa IR, Costa ICC, Pérez MMB, Souza DLB. Desigualdades socioeconômicas e mortalidade por câncer: um estudo ecológico no Brasil.Revista Brasileira em Promoção da Saúde. 2016; 29(3), 350-356. DOI: https://doi.org/10.5020/18061230.2016.p350

Callado AN, Bezerra IMP, de Alcantara Sousa LV, de Abreu LC. Mortality and hospitalization for liver disease in the western Amazon from 2008 to 2017. Journal of Human Growth and Development. 2021; 31(1), 116-124. DOI: https://doi.org/10.36311/jhgd.v31.11066

Menezes MFB, Camargo TC, Guedes MTS, Alcântara, LFF. Câncer, pobreza e desenvolvimento humano: desafios para a assistência de enfermagem em oncologia. Revista Latino-Americana de Enfermagem. 2007; 15, 780-788. DOI: https://doi.org/10.1590/S0104-11692007000700011

PNUD. Programa das Nações Unidas para o Desenvolvimento. Relatório do Desenvolvimento Humano 2006. A água para lá da escassez: poder, pobreza e a crise mundial da água. New York; 2016 [acesso em 26 de julho de 2019]. Disponível em: http://www. pnud.org.br/rdh/

AtlasBR. Atlas do Desenvolvimento Humano no Brasil. [acesso em 28 de julho 2019]. Disponível em: http://www.atlasbrasil.org.br/

Roig JJ, Souza DLB, Medeiros PFM, Barbosa IR, Curado MP, et al. Future burden of prostate cancer mortality in Brazil: a population-based study. Cad. Saúde Pública. 2014; 30(11): 2451-2458. DOI: https://doi.org/10.1590/0102-311X00007314

Instituto Brasileiro de Geografia e Estatística (IBGE). [Agência IBGE Notícias]. Em 2015, esperança de vida ao nascer era de 75,5 anos [acesso em 20 de dezembro de 2018]. Disponível em: https://agenciadenoticias.ibge.gov.br/agencia-sala-de-imprensa/2013-agencia-de-noticias/releases/9490-em-2015-esperanca-de-vida-ao-nascer-era-de-75-5-anos

Curado MP, Edwards B, Shin RH, Storm H, Ferlay J, et al. Cancer incidence in five continentes. Volume IX. França: IARC Press, International Agency for Research on Cancer; 2017.

Oliveira MM, Malta DC, Guauche H, de Moura L, Silva GA. Estimated number of people diagnosed with cancer in Brazil: data from the National Health Survey, 2013. Revista Brasileira de Epidemiologia. 2015; 18(2): 146-157. DOI: https://doi.org/10.1590/1980-5497201500060013

Barrington WE, Schenk JM, Etzioni R, et al. Difference in association of obesity with prostate cancer risk between US African American and non-hispanic white men in the selenium and vitamin e cancer prevention trial (SELECT). JAMA Oncol. 2015;1(3):342-349. DOl: https://doi.org/10.1001/jamaoncol.2015.0513

Brasil. Lei nº 12.732, de 22 de novembro de 2012. Dispõe sobre o primeiro tratamento de paciente com neoplasia maligna comprovada e estabelece prazo para seu início. Diário Oficial da União. Brasília, 2012; Seção1:1-2. Disponível: http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2012/lei/l12732.htm

Quijada PDDS, Fernandes PA, Oliveira DS, Santos BMDO. Câncer de próstata: retrato de uma realidade de pacientes em tratamento. Rev. enferm. UFPE online. 2017; 11(6): 2490-2499.

Published

2021-08-03

Issue

Section

ORIGINAL ARTICLES